Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019

SELL
$16.0 - $31.84 $204,288 - $406,533
-12,768 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$24.32 - $37.54 $9,728 - $15,016
400 Added 3.23%
12,768 $409,000
Q2 2018

Jul 31, 2018

BUY
$26.61 - $27.78 $329,112 - $343,583
12,368 New
12,368 $329,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $64M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.